Clinical Trials List
Protocol NumberCAIN457M2301E1
Completed
2020-08-01 - 2026-06-04
Phase III
Recruiting2
ICD-10L73.2
Hidradenitis suppurativa
ICD-9705.83
Hidradenitis
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳吉妮 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
745 participants
